The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.

News of a respiratory virus spreading in China and footage of crowded hospitals has predictably led to panic among the people ...

In a statement released Tuesday, the World Health Organization summed up the situation: ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.

Experts attribute this vulnerability to immature immune systems in infants and the waning of maternal antibodies during the ...

GSK (GSK) and Pfizer (PFE) vaccines for respiratory syncytial virus, or RSV, will carry warnings that they can increase the risk of developing ...

“In transplant recipients, particularly kidney and lung transplant patients, HMPV can cause significant morbidity.

The Arkansas Department of Health tracks viral respiratory diseases, including influenza, COVID-19, and respiratory syncytial ...

India TV’s claims that HMPV is a mysterious virus, or speculation that a new virus may have arisen out of China, are false.

Vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public.